Complete report $8,300.  DataPack (test volumes, sales forecasts, supplier shares) $5,400.This new 335-page report from VPGMarketResearch.com provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.  About this ReportThis report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK) .  Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales forecasts by country and market segment, including:     - Hospitals     - Commercial/Private Labs     - Physician Offices     - Public Health Labs       In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.  Also, the report:     -  Examines market applications of Molecular Diagnostics,          Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen      -  Reviews features and operating characteristics of major analyzers used         for respiratory disease... Research Beam Model: Research Beam Product ID: 301791 0 USD New
2015 Strategies in the European Respiratory Diseases Diagnostic Testing Market
 

2015 Strategies in the European Respiratory Diseases Diagnostic Testing Market

2015 Strategies in the European Respiratory Diseases Diagnostic Testing Market

Category : Diagnostic and Biotech
Published On : May  2015
Pages : 335



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com

Complete report $8,300.  DataPack (test volumes, sales forecasts, supplier shares) $5,400.

This new 335-page report from VPGMarketResearch.com provides analysis of the European respiratory disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. 

About this Report

This report presents detailed analysis of the Respiratory Disease market in Europe (France, Germany, Italy, Spain, UK) .  Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.  The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of respiratory disease diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies; thirteen

     -  Reviews features and operating characteristics of major analyzers used
        for respiratory disease testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies,  
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the five major European countries.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group’s proprietary data files was conducted.

Contains 335 pages and 76 tables



Enquiry Before Buy